The relevance of drug DNA sequence specificity to anti-tumour activity
- 31 December 1994
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (4) , 567-568
- https://doi.org/10.1016/0959-8049(94)90449-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivoNature, 1992
- Antiparallel side-by-side dimeric motif for sequence-specific recognition in the minor groove of DNA by the designed peptide 1-methylimidazole-2-carboxamide netropsin.Proceedings of the National Academy of Sciences, 1992
- Design and binding of a distamycin A analog to d(CGCAAGTTGGC).cntdot.d(GCCAACTTGCG): synthesis, NMR studies, and implications for the design of sequence-specific minor groove binding oligopeptidesJournal of the American Chemical Society, 1992
- Rational design of a highly efficient irreversible DNA interstrand cross-linking agent based on the pyrrolobenzodiazepine ring systemJournal of the American Chemical Society, 1992
- Effect of linker length on DNA-binding affinity, cross-linking efficiency and cytotoxicity of C8-linked pyrrolobenzodiazepine dimersJournal of the Chemical Society, Chemical Communications, 1992
- Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agentsNucleic Acids Research, 1990
- DNA and associated targets for drug designJournal of Medicinal Chemistry, 1989
- Site-Specific Oligonucleotide Binding Represses Transcription of the Human c- myc Gene in VitroScience, 1988
- Design of Sequence-Specific DNA-Binding MoleculesScience, 1986